| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $642.8M | +5.2% |
| Cost of Revenue | $198.9M | +1.3% |
| Gross Profit | $443.9M | +7.1% |
| R&D Expense | $238.6M | -9.8% |
| SG&A Expense | $316.1M | -8.2% |
| Operating Income | -$61.0M | +68.7% |
| Pre-tax Income | -$39.9M | +77.5% |
| Income Tax | $3.6M | -26.2% |
| Net Income | -$43.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $47.0M | -46.5% |
| Inventory | $56.3M | -32.2% |
| Current Assets | $684.5M | +17.1% |
| Total Assets | $1.04B | +13.4% |
| Current Liabilities | $153.5M | +30.5% |
| Total Liabilities | $245.0M | +17.5% |
| Stockholders' Equity | $796.3M | +12.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.1M | +1941.6% |
| Capital Expenditures | $5.9M | -52.1% |
| Investing Cash Flow | -$13.4M | +58.8% |
| Financing Cash Flow | $6.8M | -37.7% |
| Free Cash Flow | $130.1M | +2371.2% |
| +76.2% |
| EPS (Basic) | -$0.35 | +77.0% |
| EPS (Diluted) | -$0.35 | +77.0% |